Szarkóma: vizsgálatok itt: Hollandia
27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Almelo, Ede Gld, Harderwijk, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 2. fázisTaking peopleKEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Where
- Deventer, Leiden
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Geleen, 'S-Hertogenbosch
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Utrecht
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 3. fázisTaking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Groningen, Leiden, Nijmegen, Utrecht
- Életkor
- 4 év and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - 2. fázisTaking peoplePan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 153
- Run by
- Netherlands Cancer Institute
See details and how to joinNCT06279130 · EU 2023-505756-21-00 - 3. fázisTaking peopleSurgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- Amsterdam, Leiden, Nijmegen
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677 - 3. fázisTaking peopleA Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 16 worldwide
- Run by
- Rezolute
See details and how to joinNCT06881992 - 1. fázisTaking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Groningen, Leiden
- Életkor
- 12 év to 85 év
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - 1. fázisTaking peopleFirst-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644755 - 1. fázisTaking peopleLong-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Where
- Amsterdam
- People
- 7 worldwide
- Run by
- USWM Ct LLC
See details and how to join2024-513033-21-00 - No phaseTaking peopleProspective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Australia and New Zealand Sarcoma Association
See details and how to joinNCT07377747 - 1/2. fázisTaking peopleMaster Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
- Where
- Amsterdam, Nijmegen
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Anocca AB
See details and how to joinNCT07145450 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Amsterdam, Groningen
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 2. fázisTaking peopleIndocyanine Green and near infrared fLuorescence in paediatric Oncology surgery
- Where
- Utrecht
- People
- 30
- Run by
- The University Of Birmingham
See details and how to join2024-514089-37-00 - 2/3. fázisNot yet taking people in HollandiaThe Surf trial
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 40
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2025-523898-42-00 - No phaseTaking peopleShort Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen
- Életkor
- 18 év and over
- People
- 150
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07071727 - Korai 1. fázisTaking peoplePET-imaging of Two Vartumabs in Patients With Solid Tumors
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 32
- Run by
- Var2 Pharmaceuticals
See details and how to joinNCT06645808 · EU 2024-513827-18-00 - No phaseTaking peopleOutcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 150
- Run by
- Amsterdam UMC
See details and how to joinNCT06962072 - No phaseTaking peopleEarly Ageing During Therapy in AYA Cancer Patients
- Where
- Groningen
- Életkor
- 18 év to 39 év
- People
- 120
- Run by
- University Medical Center Groningen
See details and how to joinNCT05062707 - 1. fázisNot yet taking people in HollandiaEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Where
- Amsterdam, Groningen
- Életkor
- 18 év and over
- People
- 55 worldwide
- Run by
- Medigene AG
See details and how to joinNCT06748872 · EU 2024-516787-28-00 - No phaseNot yet taking people in HollandiaQuantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 30
- Run by
- University Medical Center Groningen
See details and how to joinNCT06726512 - 2/3. fázisTaking peoplerEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
- Where
- Nijmegen, Utrecht
- People
- 436 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-516078-31-00 - 1/2. fázisTaking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Groningen, Utrecht
- People
- 1672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00 - No phaseTaking peopleImage Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas
- Where
- Delft, Leiden
- Életkor
- 50 év and over
- People
- 40
- Run by
- Leiden University Medical Center
See details and how to joinNCT04832620